Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory
demyelinating disorders of the central nervous system that involves the optic nerve and …

Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune
disease of the central nervous system that causes recurrent attacks of optic neuritis, myelitis …

Background Optic neuritis (ON) is the most common manifestation of myelin oligodendrocyte
glycoprotein antibody associated disorder (MOGAD) and multiple sclerosis (MS). Acute ON …

Optic neuritis (ON) is the most common cause of subacute optic neuropathy in young adults.
Although most cases of optic neuritis (ON) are classified as typical, meaning idiopathic or …

CD8+ T cells outnumber CD4+ cells in multiple sclerosis (MS) lesions associated with
disease progression, but the pathogenic role and antigenic targets of these clonally …

The optic nerve is known to be one of the largest nerve bundles in the human central
nervous system. There have been many studies of optic nerve imaging and post-processing …

Optic neuritis (ON) is one of the most frequently seen neuro-ophthalmic causes of vision loss
worldwide. Typical ON is often idiopathic or seen in patients with multiple sclerosis, which is …

Inebilizumab, a humanized, glycoengineered, IgG1 monoclonal antibody that depletes
CD19+ B‐cells, is approved to treat aquaporin 4 (AQP4) IgG‐seropositive neuromyelitis …

Visual field (VF) testing is an essential component of the neurological examination. The
differential diagnosis of VF defects depends on relating this measure of afferent visual …

Background Inebilizumab, an anti-CD19 B cell-depleting antibody, reduced the risk of a
neuromyelitis optica spectrum disorder (NMOSD) attack, disability worsening, magnetic …